Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging
Proceedings of the National Academy of Sciences · 17.06.2025 · 122 (24)
DOI: 10.1073/pnas.2504950122 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.06.2025. Verfasst von Nisi Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University, Stanford, CA 94304. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Glutamate Carboxypeptidase II, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI), Leukemia and Lymphoma Society (LLS).
Abstract (Originalsprache)
In situ T cell transfection methods overcome the complexity and high costs associated with conventional chimeric antigen receptor (CAR)-T therapy. However, the in situ CAR-T cell approach operates within the patient’s complex immune environment and bypasses preinfusion ex vivo cellular quality controls, necessitating advanced imaging techniques to track immune cell migration and function. Positron emission tomography (PET) can detect biochemical processes in patients and, when combined with a radiotracer specific for the engineered cells, can monitor CAR-T cell trafficking. Herein, we develop an approach for in situ T cell generation, tracking, and functional assessment using anti-CD5-conjugated lipid nanoparticles for codelivering CD19 CAR mRNA (mCAR19) and a prostate-specific membrane antigen mRNA (mPSMA) tag. With interleukin-7 (IL-7) preconditioning and repeated administration, this approach achieves tumor-free survival in 75% of B cell lymphoma-bearing mice (similar efficacy to ex vivo approaches), and through PET imaging of 68 Ga-PSMA-617, the generation and tumor infiltration of in situ-engineered PSMA-tagged CD19 CAR-T cells is validated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University, Stanford, CA 94304.
- Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305.
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
ORCID-Profile: Nisi Zhang, Jai Woong Seo, Elise Robinson, Spencer K Tumbale, Marina N Raie, Gokce Engudar, Ronald Levy, Katherine W Ferrara
Förderung
- NCI NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
- Leukemia and Lymphoma Society (LLS)
- NIBIB NIH HHS
- HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Zitieren
APA
Zhang, N., Seo, J. W., Robinson, E., Rivera-Rodriguez, A., Wang, J., Guo, Y., Czerwinski, D. K., Kim, H. R., Tumbale, S. K., Raie, M. N., Jan, B. L., Engudar, G., Sallets, A., Minn, I., Pomper, M. G., Levy, R., & Ferrara, K. W. (2025). Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging. Proceedings of the National Academy of Sciences, 122(24). https://doi.org/10.1073/pnas.2504950122
Vancouver
Zhang N, Seo JW, Robinson E, Rivera-Rodriguez A, Wang J, Guo Y, et al. Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging. Proceedings of the National Academy of Sciences. 2025;122(24). doi:10.1073/pnas.2504950122
BibTeX
@article{Zhang2025,
author = {Zhang, Nisi and Seo, Jai Woong and Robinson, Elise and Rivera-Rodriguez, Angelie and Wang, James and Guo, Yutong and Czerwinski, Debra K and Kim, Ha Rin and Tumbale, Spencer K and Raie, Marina N and Jan, Basit L and Engudar, Gokce and Sallets, Adrienne and Minn, Il and Pomper, Martin G and Levy, Ronald and Ferrara, Katherine W},
title = {Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {24},
doi = {10.1073/pnas.2504950122}
}
EUVIMED